טוען...
Malate dehydrogenase 2 confers docetaxel resistance via regulations of JNK signaling and oxidative metabolism
BACKGROUND: Resistance to chemotherapy represents a significant obstacle in prostate cancer therapeutics. Novel mechanistic understandings in cancer cell chemotherapeutic sensitivity and resistance can optimize treatment and improve patient outcome. Molecular alterations in the metabolic pathways ar...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3888097/ https://ncbi.nlm.nih.gov/pubmed/23389923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22650 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|